Not applicableNot Yet RecruitingNCT05371392What this trial is testingPolymorphism of ITGA4 Gene in Chronic Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic Leukemia Sohag University 80
Large-scale testing (Phase 3)Active Not RecruitingNCT01886872What this trial is testingRituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic LeukemiaWho this might be right forStage I Chronic Lymphocytic LeukemiaStage II Chronic Lymphocytic LeukemiaStage III Chronic Lymphocytic Leukemia+1 more National Cancer Institute (NCI) 547
Not applicableStudy completedNCT00521430What this trial is testingDonor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other DiseaseWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+3 more Asan Medical Center 30
Early research (Phase 1)Looking for participantsNCT06547528What this trial is testingA Phase I Study to Investigate the Tolerability and Safety of ONO-4685 Given as Monotherapy in T Cell Lymphoma and CLL/SLLWho this might be right forRelapsed or Refractory T Cell Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Ono Pharmaceutical Co., Ltd. 108
Not applicableUnknownNCT03971565What this trial is testingEvaluation of the Redox Profiles of Healthy and Pathological B Cells in Patients With Chronic Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic Leukemia Assistance Publique Hopitaux De Marseille 47
Testing effectiveness (Phase 2)Study completedNCT01532700What this trial is testingAn Open-Label Phase 2 Study of Ofatumumab (Arzerra) in Combination With Oral GSK2110183 in the Treatment of Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL)Who this might be right forChronic Lymphocytic Leukemia (CLL) University Health Network, Toronto 28
Early research (Phase 1)Study completedNCT01373229What this trial is testingLenalidomide + Plerixafor in Previously Treated Chronic Lymphocytic Leukemia (CLL)Who this might be right forLeukemia, Lymphocytic, Chronic, B-Cell David Rizzieri, MD 21
Testing effectiveness (Phase 2)Study completedNCT01246557What this trial is testingStudy Assessing Safety and Efficiency of the Lenalidomide and Dexamethasone Combination in Patients With Chronic Lymphatic Leukemia (CLL) Relapsing or Resistant to TreatmentWho this might be right forChronic Lymphatic Leukemia Hospital Universitari Vall d'Hebron Research Institute 20
Testing effectiveness (Phase 2)Study completedNCT02533401What this trial is testingRituximab (MabThera) in Participants With Chronic Lymphocytic Leukemia (CLL)Who this might be right forLymphocytic Leukemia, Chronic Hoffmann-La Roche 34
Testing effectiveness (Phase 2)Looking for participantsNCT05147467What this trial is testingStudy of APG-2575 in Patients With Relapsed/Refractory CLL/SLLWho this might be right forChronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma Ascentage Pharma Group Inc. 75
Early research (Phase 1)Study completedNCT00161187What this trial is testingIrradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid TumorWho this might be right forCancer University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)WithdrawnNCT00845104What this trial is testingFludarabine Phosphate, Rituximab, and Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia That Has Relapsed or Not Responded To TreatmentWho this might be right forB-cell Chronic Lymphocytic LeukemiaRefractory Chronic Lymphocytic Leukemia Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Early research (Phase 1)UnknownNCT06209671What this trial is testingINS19 CAR-T Cells for the Treatment of Relapsed or Refractory Acute B Lymphoblastic LeukemiaWho this might be right forLeukemia, B-cell Beijing Immunochina Medical Science & Technology Co., Ltd. 12
Testing effectiveness (Phase 2)Study completedNCT02968563What this trial is testingStudy to Evaluate the Safety and Efficacy of the Combination of Tirabrutinib and Idelalisib With and Without Obinutuzumab in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)Who this might be right forChronic Lymphocytic Leukemia Gilead Sciences 35
Testing effectiveness (Phase 2)UnknownNCT04714593What this trial is testingTargeting CD19 and CD22 CAR-T Cells Immunotherapy in Patients With Relapsed or Refractory Acute B Lymphocytic LeukemiaWho this might be right forAcute Lymphocytic Leukemia， B-Cell Shanxi Province Cancer Hospital 24
Testing effectiveness (Phase 2)WithdrawnNCT01652014What this trial is testingSingle or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic MalignanciesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in Remission+51 more University of Medicine and Dentistry of New Jersey
Testing effectiveness (Phase 2)Active Not RecruitingNCT05761171What this trial is testingRevumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory LeukemiaWho this might be right forRecurrent Acute Leukemia of Ambiguous LineageRecurrent Acute Lymphoblastic LeukemiaRecurrent Acute Myeloid Leukemia Due to Lineage Switch From Acute Leukemia of Ambiguous Lineage+9 more Children's Oncology Group 78
Testing effectiveness (Phase 2)Study completedNCT01868893What this trial is testingAn Expanded Access, Open-Label Study of Obinutuzumab (GA101) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic Leukemia Genentech, Inc. 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06777264What this trial is testingInaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment for Newly Diagnosed B-cell ALL Patients in CR1Who this might be right forAcute Lymphoblastic LeukemiaB Cell ALL First Affiliated Hospital of Zhejiang University 20
Not applicableStudy completedNCT03582098What this trial is testingClinical Outcomes and Routine Management of Adults With Chronic Lymphocytic Leukaemia Treated With Idelalisib and Rituximab in the United Kingdom (UK) and IrelandWho this might be right forChronic Lymphocytic Leukaemia Gilead Sciences 112